Synnovation is committed to discovering and developing breakthrough precision medicines that address significant unmet medical needs. Our pipeline is built around highly validated precision targets where greater potency, selectivity and optimized pharmaceutical and drug-like properties have the potential to address liabilities in existing standards of care, and meaningfully improve patient outcomes.